BMY · NYSE · Pharmaceuticals
Stock since the trade -4.6% · S&P 500 +0.2% · to Oct 1Traded 41 days after resultsStock 51% above its 52-week low and 5% below its high
25K → 19K shares held−25% of their stake
Bristol Myers Squibb's Chief Med Offr,Head of Dev sold $403K of Bristol Myers Squibb shares. Nobody planned it ahead of time.
Officer plans to sell ~$403K of Bristol Myers Squibb
Planned, from payStock since the trade -9.5% · S&P 500 -0.3% · to Oct 1Traded 26 days after resultsStock at its 52-week high, after a 19% rise in the previous month
17K → 17K shares held−3% of their stake
Bristol Myers Squibb's SVP and Controller sold $34K of Bristol Myers Squibb shares. Nobody planned it ahead of time.
CFO sold ~$1.57M of Bristol Myers Squibb
Scheduled in advanceCFO sold ~$278K of Bristol Myers Squibb
Scheduled in advance
